Challenging the transcatheter-first paradigm: Redo surgical aortic valve replacement after previous transcatheter or surgical aortic valve replacement
TAVR-SAVR cases are increasing and may surpass SAVR-SAVR cases by 2029. Despite matching, patients undergoing SAVR ± coronary artery bypass grafting showed worse outcomes in TAVR-SAVR, whereas a SAVR-SAVR strategy was extremely safe. Reconsideration of the TAVR-first strategy is warranted for patients expected to outlive the durability of TAVR prostheses.
Authors
- Robert B. Hawkins (ORCID: https://orcid.org/0000-0002-3959-8201)
- Gorav Ailawadi (ORCID: https://orcid.org/0000-0002-2846-4726)
- Bo Yang (ORCID: https://orcid.org/0000-0002-1347-3718)
- Shinichi Fukuhara (ORCID: https://orcid.org/0000-0002-7898-5159)
- Himanshu J. Patel (ORCID: https://orcid.org/0000-0001-7639-2416)
- Barbara C.S. Hamilton (ORCID: https://orcid.org/0000-0002-5498-3378)
- Carol Ling (ORCID: https://orcid.org/0009-0008-7206-1095)
Institutions
- University of Michigan (US)
- Michigan Medicine (US)
Publication Details
- Journal
- Journal of Thoracic and Cardiovascular Surgery
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1016/j.jtcvs.2025.08.014
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00